GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioton SA (OTCPK:BOIOF) » Definitions » EV-to-EBITDA

Bioton (Bioton) EV-to-EBITDA : 0.00 (As of May. 26, 2024)


View and export this data going back to . Start your Free Trial

What is Bioton EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bioton's enterprise value is $0.00 Mil. Bioton's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $11.34 Mil. Therefore, Bioton's EV-to-EBITDA for today is 0.00.

The historical rank and industry rank for Bioton's EV-to-EBITDA or its related term are showing as below:

BOIOF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -7.55   Med: 9.26   Max: 3427.34
Current: 8.09

During the past 13 years, the highest EV-to-EBITDA of Bioton was 3427.34. The lowest was -7.55. And the median was 9.26.

BOIOF's EV-to-EBITDA is ranked better than
54.1% of 451 companies
in the Biotechnology industry
Industry Median: 9.67 vs BOIOF: 8.09

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), Bioton's stock price is $0.00. Bioton's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.000. Therefore, Bioton's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Bioton EV-to-EBITDA Historical Data

The historical data trend for Bioton's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioton EV-to-EBITDA Chart

Bioton Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.62 5.86 10.35 7.55 7.36

Bioton Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.96 7.69 9.63 7.36 8.22

Competitive Comparison of Bioton's EV-to-EBITDA

For the Biotechnology subindustry, Bioton's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioton's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioton's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bioton's EV-to-EBITDA falls into.



Bioton EV-to-EBITDA Calculation

Bioton's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/11.343
=0.00

Bioton's current Enterprise Value is $0.00 Mil.
Bioton's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioton  (OTCPK:BOIOF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bioton's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.00/0.000
=N/A

Bioton's share price for today is $0.00.
Bioton's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Bioton EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bioton's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioton (Bioton) Business Description

Traded in Other Exchanges
Address
Ul. Staro?ci?ska 5, Warszawa, POL, 02-516
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.

Bioton (Bioton) Headlines

No Headlines